Mach7 TechnologiesTDMMF -10.12%32 Net Current Asset Value is $0.03 as of Dec. 2025, which is 100% below its 10-year median of 12.40. GuruFocus rates TDMMF with a GF Score™ of 32/100 and a GF Value™ of $0.65 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 273 Healthcare Providers & Services companies, Mach7 Technologies ranks worse than 56.04% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Mach7 Technologies's net current asset value per share for the quarter that ended in Dec. 2025 was $0.03.
The historical rank and industry rank for Mach7 Technologies's Net Current Asset Value or its related term are showing as below:
TDMMF'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 4.62 Med: 12.4 Max: 125
Current: 7.11
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Mach7 Technologies was 125.00. The lowest was 4.62. And the median was 12.40.
TDMMF's Price-to-Net-Current-Asset-Value is ranked worse than 56.04% of 273
companies
in the Healthcare Providers & Services industry
Industry Median: 6.11
vs TDMMF: 7.11
Mach7 Technologies (OTCPK:TDMMF) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Mach7 Technologies Net Current Asset Value Related Terms
Mach7 Technologies Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Mach7 Technologies's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TDMMF vs VEEV, BTSG, TEM: Net Current Asset Value Comparison
For the Health Information Services subindustry, Mach7 Technologies's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mach7 Technologies Price-to-Net-Current-Asset-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Mach7 Technologies's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $0.03 mean?
Mach7 Technologies (TDMMF) has a Net Current Asset Value of $0.03 as of Dec. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Mach7 Technologies and its competitors. This is 100% below median its historical median of 12.40. Over the past decade, Mach7 Technologies' Net Current Asset Value has ranged from 4.62 to 125.00. According to the industry distribution chart, Mach7 Technologies ranks #153 out of 273 companies in the Healthcare Providers & Services industry, placing it in the top 56%.
Is Mach7 Technologies' Net Current Asset Value too high?
Mach7 Technologies' current Net Current Asset Value of $0.03 is 100% below median its 10-year median of 12.40. Over the past 10 years, this metric has ranged from a low of 4.62 to a high of 125.00. The Healthcare Providers & Services industry median Net Current Asset Value is 6.11. Mach7 Technologies' value of $0.03 is 99.5% below this industry median. Based on the distribution chart, Mach7 Technologies ranks #153 out of 273 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Mach7 Technologies has a GF Score™ of 32/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mach7 Technologies' Net Current Asset Value compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mach7 Technologies ranks #153 out of 273 companies for Net Current Asset Value. This places Mach7 Technologies in the lower half of its industry. The industry median Net Current Asset Value is 6.11. Mach7 Technologies' value of $0.03 is 99.5% below this benchmark. Historically, Mach7 Technologies' own Net Current Asset Value has ranged from 4.62 to 125.00 over the past decade. While the company's 10-year median is 12.40 vs. the industry median of 6.11, Mach7 Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Healthcare Providers & Services company?
The median Net Current Asset Value among Healthcare Providers & Services companies is 6.11, based on 273 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mach7 Technologies's current Net Current Asset Value of $0.03 is 99.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Mach7 Technologies and its competitors. For the Healthcare Providers & Services industry, the median Net Current Asset Value is 6.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mach7 Technologies's current Net Current Asset Value is $0.03, which is 100% below median its own 10-year median of 12.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mach7 Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mach7 Technologies (TDMMF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.65, compared to a current price of $0.21 — trading 67.2% below its estimated fair value. The current Net Current Asset Value is $0.03, which is 100% below median its 10-year median of 12.40 and 99.5% below the Healthcare Providers & Services industry median of 6.11. Mach7 Technologies' overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Mach7 Technologies (TDMMF), the current Net Current Asset Value is $0.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mach7 Technologies (TDMMF) Overvalued in 2026?
Based on GuruFocus' analysis, Mach7 Technologies stock appears to be undervalued.
The current stock price of $0.21 is trading 67.2% below its estimated GF Value™ of $0.65.
GuruFocus considers Mach7 Technologies to be Possible Value Trap.
Key valuation signals for TDMMF:
Net Current Asset Value: $0.03 (100% below median its 10-year median of 12.40)
GF Value™: $0.65 vs. price of $0.21 (67.2% below fair value)
Industry Position: 99.5% below the Healthcare Providers & Services median (#153 of 273)
No single metric tells the full story. See the TDMMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mach7 Technologies Ltd is a healthcare software company focused on enterprise imaging infrastructure. The company's vendor neutral platform enables health systems to manage, access, and exchange medical imaging data across departments, sites, and vendors. It serves across North America, Asia-Pacific, and the Middle East, with deployments ranging from academic medical centres to multi-site health networks. A substantial part of revenue is derived in the form of Subscription revenue. Geographically, it derives a majority of its revenue from North America.
32GF Score
Get the complete analysis for TDMMF
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TDMMF has been successfully added to your 
